InnoCan Pharma (XCNQ:INNO) Other Operating Expense : C$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InnoCan Pharma Other Operating Expense?

InnoCan Pharma's Other Operating Expense for the three months ended in Dec. 2023 was C$-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

InnoCan Pharma's quarterly Other Operating Expense increased from Jun. 2023 (C$-0.00 Mil) to Sep. 2023 (C$0.00 Mil) but then declined from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$-0.00 Mil).

InnoCan Pharma's annual Other Operating Expense increased from Dec. 2021 (C$-0.00 Mil) to Dec. 2022 (C$-0.00 Mil) and increased from Dec. 2022 (C$-0.00 Mil) to Dec. 2023 (C$0.00 Mil).

InnoCan Pharma Other Operating Expense Historical Data

The historical data trend for InnoCan Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Other Operating Expense Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-0.27

InnoCan Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

InnoCan Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

InnoCan Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (XCNQ:INNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (XCNQ:INNO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

INNPF:USA IP4:Germany

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.

InnoCan Pharma (XCNQ:INNO) Headlines

From GuruFocus

Innocap, Inc. Current Activities - Salvage Ship Has Departed Singapore For Recovery Operations

By Marketwired Marketwired • 06-28-2018

Unique Logistics Holdings, Inc. and Innocap, Inc. Complete Reverse Merger and Financing

By PRNewswire PRNewswire • 10-27-2020

President of Innocap, Inc. is in Singapore

By GlobeNewswire GlobeNewswire • 05-03-2018

Innocap, Inc.'s Current Activities

By Marketwired Marketwired • 05-24-2018

Innocap, Inc. Year End Message To Shareholders

By PRNewswire PRNewswire • 12-14-2020

President of Innocap, Inc. is in Singapore

By Marketwired Marketwired • 05-03-2018